Buy KalVista Pharma Stock | KALV Stock Price & Latest News | Public
KALV

KalVista Pharma

$0.00 (0.00%)Today
    Small Market Cap

    About KALV

    KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors. Its product candidates are inhibitors of plasma kallikrein being developed for two indica...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.25
    -0.5
    -0.75
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.75

    Actual EPS
    Q2 2021

    Stats

    Market Cap$333,26M
    Volume3,95k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$20.01
    1 Year Low$5.61
    Open$18.83
    High$19.44
    Low$18.72

    Buy any stock with any amount of money.

    Download the App
    Download the app